K Hynix (SKHY) plans to pay 0.5% of proceeds from its Nasdaq listing to banks working on the IPO, marking one of the largest ...

With the first half of 2026 now behind us, today’s charts will display Year-to-Date sorting, rather than our customary weekly ...

BioNTech (BNTX) stock is in focus as the company holds talks with prospective bidders regarding plans to shutter ...

For June, the S&P 500 Real Estate Index Sector (SP500-60) increased 0.23% month-over-month 279.69 points, while the ...

Micron Technology (MU) stock is in focus as the company holds a groundbreaking ceremony for expansion work at its factory in ...

Allogene Therapeutics offers upside potential driven by the pivotal ALPHA3 trial for Cema-cel in first-line large B-cell ...

Build a resilient portfolio with a simple 4-point blueprint: diversify across 42+ positions, reinvest 25% cashflows, and win ...

Novo Nordisk (NVO) rated Buy as oral Wegovy lifts GLP-1 sales, expands obesity market and boosts 2026 guidance.

The global macro remains on uneven footing, and Latin America is especially exposed to shifting U.S. trade policy. In-region ...

S&P 500 earnings surged 60% in 3 years—dot-com bust fears? See why cash flows, capex discipline, and stricter accounting may ...

Vince Holding Corp. is executing a turnaround, focusing on premium apparel, e-commerce, and operational efficiency. Learn why ...

Lumentum investors have benefited from the gold rush in AI optical networking plays suggesting patience. Read why LITE stock ...